Sudden deafness …

Douglas J Lanska MD MS MSPH

Neuro-Ophthalmology & Neuro-Otology

Updated 05.14.2024
Released 09.10.2001
Expires For CME 05.14.2027

Sudden deafness

Author: Douglas J Lanska MD MS MSPH

See Contributor Disclosures

Sudden deafness

In This Article

Quick Link

Introduction

Overview

The author explains the clinical presentation, pathophysiology, diagnostic work-up, and management of sudden deafness. "Sudden" deafness is defined as sensorineural hearing loss of 30 decibels or more in at least three contiguous frequencies occurring over less than 3 days. The pathophysiology of sudden deafness is poorly understood. Various theories have been proposed, including those attributing sudden deafness to vascular insults, infectious (especially viral) agents, autoimmune or inflammatory mechanisms, or disruption of labyrinthine membranes. Despite extensive investigation, most cases remain idiopathic. Systemic steroids, or a combination of systemic and intratympanic steroids, are commonly recommended, but some employ intratympanic steroid therapy as a first-line therapy because systemic and transtympanic administration of corticosteroids has been found to result in similar clinical outcomes. Intratympanic steroid perfusion should be offered in patients with incomplete recovery from idiopathic sudden sensorineural hearing loss after failure of initial management, and when used as salvage therapy, intratympanic steroids can result in significant gains in hearing. The overall prognosis depends on the underlying etiology, but a high rate of spontaneous resolution occurs overall (ie, about two thirds of cases). For those who do not recover from idiopathic sudden deafness in their only hearing ear (ie, producing bilateral deafness), cochlear implantation can be considered as early as 3 months after initiating treatment of sudden deafness.

Key points

	• "Sudden" deafness is defined as sensorineural hearing loss of 30 decibels or more in at least three contiguous frequencies, occurring over less than 3 days.
	• In patients with sudden sensorineural hearing loss, tinnitus is associated with worse high-frequency hearing loss, whereas aural fullness and pressure sensations are typically associated with low-frequency hearing loss.
	• The clinical manifestations of ischemia of the inner ear can include unilateral deafness and tinnitus as well as acute vertigo, nausea and vomiting, imbalance, and canal paresis.
	• The spectrum of clinical presentation of anterior inferior cerebellar artery infarction includes ipsilateral hearing loss with or without tinnitus as well as a range of labyrinthine, brainstem, and cerebellar symptoms and signs.
	• The spectrum of clinical presentation of superior cerebellar artery syndrome includes ipsilateral Horner syndrome, ipsilateral limb ataxia, contralateral sensorineural hearing loss (due to involvement of the lateral lemniscus carrying decussated ascending auditory information), contralateral superficial sensory loss, vertigo, nystagmus, nausea, and vomiting.
	• Acute bilateral hearing impairment suggests vertebrobasilar occlusive disease, but hearing loss associated with vertebrobasilar insufficiency is most frequently unilateral.
	• The blood supply to the inner ear is via the internal auditory artery (also called the labyrinthine artery), which typically originates from the anterior inferior cerebellar artery.
	• Patients with unilateral idiopathic sudden sensorineural hearing loss should be evaluated for retrocochlear pathology (eg, acoustic neuroma) using magnetic resonance imaging, brainstem auditory evoked potentials, or audiometric follow-up.
	• The overall prognosis depends on the underlying etiology, but a high rate of spontaneous resolution occurs overall (ie, about two thirds of cases).
	• Management is complicated, as the underlying etiology is not known in most patients. A presumptive approach is generally employed, but no consensus exists concerning the management of sudden hearing loss.
	• Systematic syntheses and meta-analyses have failed to support the use of corticosteroids for sudden deafness and, instead, have concluded that “systemic or intratympanic steroid administration does not have a significant treatment effect.”
	• For those who do not recover from idiopathic sudden deafness in their only hearing ear (ie, producing bilateral deafness), cochlear implantation can be considered as early as 3 months after initiating treatment of sudden deafness.

Historical note and terminology

"Sudden" deafness is typically defined as sensorineural hearing loss of 30 decibels or more in at least three contiguous frequencies, occurring over less than 3 days. Some (explicitly or implicitly) consider the syndrome to apply only to "idiopathic" monophasic cases, but in this article, such restrictions are not employed.

Clinical manifestations

Presentation and course

	• By definition, the principal manifestation of sudden hearing loss is sensorineural hearing loss occurring over less than 3 days. It is usually a monophasic illness, but recurrences can occur with some etiologies.
	• Associated manifestations may include aural fullness or pressure, tinnitus, vertigo, nausea and vomiting, and various brainstem and cerebellar signs.
	• In patients with sudden sensorineural hearing loss, tinnitus is associated with worse high-frequency hearing loss, whereas aural fullness and pressure sensations are typically associated with low-frequency hearing loss.
	• The putative cause of sudden sensorineural hearing loss is identified in about 10% to 15% of cases, and the remainder is considered idiopathic after evaluation. Only approximately 1% have an identified retro-cochlear cause.
	• Putative risk factors for sudden sensorineural hearing loss include cardiovascular risk factors (smoking, increased alcohol consumption), obstructive sleep apnea (in men only), and recent subclinical viral or toxoplasmosis infections.
	• Sudden deafness may be caused by ischemia of the cochlea or eighth nerve.
	• The spectrum of clinical presentation of anterior inferior cerebellar artery infarction includes ipsilateral hearing loss with or without tinnitus as well as a range of labyrinthine, brainstem, and cerebellar symptoms and signs.
	• The spectrum of clinical presentation of superior cerebellar artery syndrome includes ipsilateral Horner syndrome, ipsilateral limb ataxia, contralateral sensorineural hearing loss (due to involvement of the lateral lemniscus carrying decussated ascending auditory information), contralateral superficial sensory loss, vertigo, nystagmus, nausea, and vomiting.
	• The "hyperviscosity syndrome" includes a number of diverse clinical manifestations, including headache, fatigue, vertigo, nystagmus, sudden or progressive hearing loss, visual disturbances, and mucosal hemorrhages. Ophthalmoscopic findings include markedly distended and tortuous ("sausage-shaped") retinal veins and retinal hemorrhages, similar to the pattern seen in retinal vein occlusion.
	• Ramsay Hunt syndrome (herpes zoster oticus) may be associated with vesicles in the external auditory canal, burning pain in the ear, unilateral Bell palsy, unilateral hearing loss, tinnitus, vertigo, and transient spontaneous nystagmus.
	• Ménière syndrome is associated with fluctuating sensorineural hearing loss, subjective tinnitus, aural fullness, episodic vertigo, and horizontal or horizontal-rotatory nystagmus.

By definition, the principal manifestation of sudden hearing loss is sensorineural hearing loss occurring over less than 3 days (92). It is usually a monophasic illness, but recurrences can occur with some etiologies (92). Depending on the etiology and on damage to associated structures, associated manifestations may include aural fullness or pressure, tinnitus, vertigo, nausea and vomiting, and various brainstem and cerebellar signs (92). In patients with sudden sensorineural hearing loss (SSNHL), tinnitus is associated with worse high-frequency hearing loss, whereas aural fullness and pressure sensations are typically associated with low-frequency hearing loss (156). Tinnitus and aural fullness improve with improvements in hearing (70).

Men and women are generally affected with equal frequency, although one study found a higher frequency among females than males (92; 129). The condition occurs most commonly in the fifth and sixth decades. For unknown reasons, the left ear is affected slightly more often than the right ear (151). The putative cause is identified in about 10% to 15% of cases, and the remainder is considered idiopathic after evaluation. Only a small minority (approximately 1%) has an identified retro-cochlear cause (eg, vestibular schwannoma, demyelinating disease, stroke) (148; 59).

Putative risk factors for sudden sensorineural hearing loss include cardiovascular risk factors (smoking, increased alcohol consumption), obstructive sleep apnea (in men only), recent subclinical viral or toxoplasmosis infections, and Sjögren syndrome (78; 107; 165; 195).

Sudden deafness may be caused by ischemia of the cochlea or eighth nerve (92). Cochlear ischemia may occur in isolation, in conjunction with labyrinthine ischemia, or in conjunction with brainstem and cerebellar ischemia as a result of involvement of the anterior inferior cerebellar artery or the vertebrobasilar system (92). The constellation of clinical manifestations depends on the extent and distribution of the ischemia. The clinical manifestations of ischemia of the inner ear can include unilateral deafness and tinnitus as well as acute vertigo, nausea and vomiting, imbalance, and canal paresis (119; 116; 46; 54; 117; 118; 134; 80; 175; 194; 146; 92). Patients with involvement of the common cochlear artery may present with deafness and vestibular involvement limited to paresis of the posterior semicircular duct (146). Patients with predominant auditory dysfunction may present with sudden deafness (46; 186), sometimes accompanied by transient dizziness and intermittent tinnitus (46; 54). Mitral valve prolapse, mitral leaflet thickening, mitral regurgitation, and left atrial enlargement are risk factors for “idiopathic” sudden sensorineural hearing loss; presumably, these associations reflect an increased risk of cochlear or eighth nerve ischemia (183).

The spectrum of clinical presentation of anterior inferior cerebellar artery infarction includes ipsilateral hearing loss with or without tinnitus as well as a range of labyrinthine, brainstem, and cerebellar symptoms and signs (92). Other manifestations include ipsilateral Horner syndrome (rare), skew deviation (rare), nystagmus, ipsilateral facial numbness, ipsilateral facial paresis, vertigo, dysarthria, vomiting, unsteadiness, ipsilateral hemiataxia, and contralateral loss of pain and temperature sensation on the limbs and body (06; 62; 134; 07; 94; 92). Occasionally, isolated vertigo or isolated auditory disturbance may occur as transient ischemic attacks preceding anterior inferior cerebellar artery-territory infarction or with partial infarcts (134; 07; 96; 105). Bilateral sudden deafness may occur as a prodrome of anterior inferior cerebellar artery-territory infarction in the presence of severe vertebrobasilar occlusive disease (98; 180). Rarely, the internal auditory artery branches off the posterior inferior cerebellar artery (rather than anterior inferior cerebellar artery), and sudden unilateral deafness may, therefore, result from posterior inferior cerebellar artery infarction (eg, with vertebral artery dissection) (150; 93).

The spectrum of clinical presentation of superior cerebellar artery syndrome includes ipsilateral Horner syndrome, ipsilateral limb ataxia, contralateral sensorineural hearing loss (due to involvement of the lateral lemniscus carrying decussated ascending auditory information), contralateral superficial sensory loss, vertigo, nystagmus, nausea, and vomiting (124).

Hearing loss occurs in about one fifth of patients with vertebrobasilar insufficiency and vertigo (194). Deafness associated with vertebrobasilar insufficiency mainly involves the cochlea, rather than central auditory pathways (194; 95). Tinnitus and vertigo are frequent accompaniments, as are a wide a range of brainstem and cerebellar symptoms and signs (100; 159).

Ischemia may also occur with vascular obstruction in the venules and capillaries, draining the inner ear, as occurs most commonly with conditions that produce marked serum hyperviscosity. The "hyperviscosity syndrome" includes a number of diverse clinical manifestations, including headache, fatigue, vertigo, nystagmus, sudden or progressive hearing loss, visual disturbances, and mucosal hemorrhages (133; 08). Ophthalmoscopic findings include markedly distended and tortuous ("sausage-shaped") retinal veins and retinal hemorrhages, similar to the pattern seen in retinal vein occlusion.

Fabry disease, an X-linked lysosomal storage disorder due to alpha-galactosidase-A deficiency, is associated with auditory manifestations, including hearing loss, sudden deafness, and tinnitus (27).

Ramsay Hunt syndrome (herpes zoster oticus) may be associated with vesicles in the external auditory canal, burning pain in the ear, unilateral Bell palsy, unilateral hearing loss, tinnitus, vertigo, and transient spontaneous nystagmus.

With viral neurolabyrinthitis, autoimmune hearing loss, and Ménière syndrome, the clinical manifestations are primarily otologic, whereas hearing loss, tinnitus, vertigo, and spontaneous nystagmus are the predominant manifestations. No neurologic manifestations are present, apart from those attributable to the labyrinth and eighth nerve.

Viral neurolabyrinthitis may be part of a systemic viral illness or an isolated viral infection of the labyrinth and eighth nerve. Many patients report an upper respiratory illness within 1 week or 2 weeks prior to the onset of symptoms. The manifestations are unilateral and may include clinically evident aural or vestibular symptoms or both (69). When hearing loss is incomplete, it is usually most severe at high frequencies. Some cases may develop posterior semicircular canal benign paroxysmal positional vertigo with preservation of lateral semicircular canal function (76).

Autoimmune hearing loss is often fluctuating, sometimes slowly progressive, and occasionally sudden. It may begin on one side but invariably becomes bilateral. It may be associated with vertigo if the involvement is sufficiently rapid and asymmetric. Often, a history of polyarteritis, rheumatoid arthritis, ulcerative colitis, Crohn disease, or other autoimmune-mediated conditions is present. Systemic manifestations may include interstitial keratitis, arthritis, rash, or gastrointestinal symptoms.

Ménière syndrome is associated with fluctuating sensorineural hearing loss, subjective tinnitus, aural fullness, episodic vertigo, and horizontal or horizontal-rotatory nystagmus. Onset may occur fairly suddenly over seconds, or it may develop over minutes or hours. The duration of hearing loss is variable among patients, with some patients having this symptom for hours, others for days or weeks, and others permanently. Even with hearing recovery with continued episodes, recovery is often less complete, resulting in a progressive hearing loss. Involvement is typically unilateral at onset but may become bilateral.

Sudden deafness can occur because of head trauma, but other manifestations of such injuries typically predominate, especially in the acute period. Rarely, sudden deafness can occur as a relatively isolated phenomenon following modest trauma. For example, Lee and colleagues reported a case of sudden, bilateral deafness associated with bilateral pneumolabyrinth, without temporal bone fracture, after a fall (99).

Sudden deafness can rarely be due to sudden-onset cortical deafness from bilateral temporal lobe infarcts (12; 125; 104). The auditory cortex is located in the posterior superior aspect of both temporal lobes, with the primary auditory cortex located in the transverse temporal gyri of Heschl. Cortical deafness may evolve to auditory agnosia (ie, impairment of the ability to interpret both verbal and nonverbal sounds even though the patient can hear them) (12) or word deafness (ie, impairment of the ability to understand speech) (125).

Bilateral sudden deafness may occur due to cerebral hemorrhage or infarction (39). In a case series of 12 Chinese patients with bilateral sudden deafness following intracranial hemorrhage or infarction, the responsible loci varied: basal ganglia hemorrhage (n=7), cerebellar hemorrhage (n=2), temporal lobe hemorrhage (n=1), thalamic infarction (n=1), and pontine hemorrhage (n=1). Five patients partially or fully recovered hearing. The cause of hearing loss in these patients was attributed to the ischemia or other damage to the central hearing conduction pathways.

Prognosis and complications

The overall prognosis depends on the underlying etiology, but a high rate of spontaneous resolution occurs overall (ie, about two thirds of cases) (41; 196; 139; 171; 92). The rate of complete recovery and the recovery rate from profound hearing loss are significantly higher in children than in adults (126). One retrospective case series of pediatric cases found that the childhood group (ages 4 to 12) had worse treatment outcomes than the adolescence group (greater than 12 years of age) (81) and another uncontrolled study reported that adolescent patients fared worse (ie, less likely to recover hearing or improve tinnitus) than adult patients with combination therapy (176).

Most patients show either initial rapid recovery or a gradual and slow recovery (56), but the spontaneous recovery that occurs typically is within the first 2 weeks after onset (111). Maximum recovery of speech discrimination occurs by 1 year after symptom onset (132). Improvement in hearing levels tends to occur mostly in the low to mid frequencies and is better in those with preserved otoacoustic emissions (70).

Those with initial rapid recovery have the best prognosis, with a smaller degree of hearing loss at the first examination, greater degree of hearing improvement, and smaller degree of residual hearing loss once stable (56). Patients with upsloping or with lower or middle-frequency hearing loss generally have a better prognosis (41; 199). Putative negative prognostic factors include longer time since onset of symptoms before treatment, more severe hearing loss, flat or downsloping audiograms, tinnitus, vertigo or evidence of vestibular dysfunction by neuro-otological studies (eg, vestibular evoked myogenic potentials and caloric testing), high signals in the affected inner ear on 3D-FLAIR MRI, very young or very old age, elevated sedimentation rate, and associated diabetes (123; 41; 199; 189; 89; 154; 178), but not all reports agree (44; 199; 148). Variation between reports depends in part on the method of outcome assessment, variation in patient characteristics including degree of hearing loss, and variation in adjustment for degree of hearing loss when considering recovery or improvement (41).

Audiovestibular residua or late effects can also include tinnitus, dysequilibrium, benign paroxysmal positioning vertigo, and Ménière syndrome (198; 69; 76; 148; 20). Annoying tinnitus and residual vertigo are the strongest predictors of the negative effects on quality of life in patients with sudden deafness (20).

Hematologic indices may be a helpful biomarker in gauging prognosis. Meta-analyses have found that the neutrophil-to-lymphocyte ratio, the platelet-to-lymphocyte ratio, the neutrophil count, and the lymphocyte count are all strongly associated with the prognosis of sudden sensorineural hearing loss (19; 26). Higher values on the neutrophil-to-lymphocyte ratio, the platelet-to-lymphocyte ratio, and the neutrophil count were predictive of worse outcomes, whereas higher lymphocyte counts were predictive of better outcomes (19; 26).

In isolated inner ear infarction, the vertigo, nystagmus, and autonomic manifestations resolve over days to weeks, but deafness and canal paresis typically remain (117; 118; 186; 80). If no brainstem symptoms develop and brain imaging is normal, the risk of recurrence or subsequent stroke is rare (117; 118; 80). Patients with labyrinthine ischemia due to vertebrobasilar insufficiency can have an overall good prognosis with anticoagulation or antiplatelet therapy (45) or, rarely, with surgical correction of a rotational vertebral artery syndrome (175). However, patients with inner ear infarction combined with brainstem or cerebellar infarcts have a worse prognosis (50), particularly if associated with occlusive disease of the basilar artery (42; 66).

Sudden sensorineural hearing loss is associated with an increased risk of subsequent stroke (106; 23; 90). In a cohort study, 13% of patients with sensorineural hearing loss had a stroke within 5 years, compared to 8% in controls, and after adjusting for other risk factors, those with sensorineural hearing loss had a risk of stroke 1.6 times greater than controls (106). Sudden hearing loss with vertigo is associated with a greater stroke risk than sudden hearing loss or vertigo alone (23).

Sudden sensorineural hearing loss can also result in later development of secondary endolymphatic hydrops with a mean interval of 8 years (29).

Anxiety and depression are frequent in patients with sudden deafness (177).

Clinical vignette

A 66-year-old diabetic man developed bilateral deafness, right-sided tinnitus, and vertigo, which he noticed on rising in the morning (98). The vertigo resolved over the next day, but the hearing loss persisted. He had no visual field loss, diplopia, Horner syndrome, dysarthria, dysphagia, weakness, ataxia, or sensory loss. A week later, he presented with worsened hearing loss in the right ear, right-sided tinnitus, vertigo, nausea, and incoordination. Examination demonstrated a spontaneous left-beating, horizontal-rotatory nystagmus; right facial hypesthesia; right peripheral facial palsy; and right-sided dysmetria. Audiometry showed moderate bilateral sensorineural hearing loss (55 dB on the right and 45 dB on the left) with 100% speech discrimination. Electronystagmography showed no response to caloric stimulation in the right ear. MRI demonstrated hyperintense foci on T2-weighted images involving the right dorsolateral pons and both middle cerebellar peduncles. MRA demonstrated moderately severe stenosis of the distal right vertebral artery and the middle third of the basilar artery. An electrocardiogram and a transthoracic echocardiogram were normal. The patient was anticoagulated. The vertigo and nausea improved over several days, and the right-sided incoordination and gait abnormalities improved over several weeks. A follow-up audiogram demonstrated profound hearing loss in the right ear and 30 dB loss in the left.

Biological basis

	• Sudden deafness may occur with interruption of peripheral or central structures involved with hearing.
	• Sudden deafness most commonly occurs with damage to the cochlea or eighth nerve.
	• Cochlear or eighth nerve infarction may occur in isolation or with concomitant infarction of the labyrinth, brainstem, and cerebellum.
	• Viral infections, inflammatory conditions, or autoimmune disorders that produce sudden hearing loss generally involve the labyrinth or eighth nerve.
	• Ménière syndrome involves the labyrinth.

Anatomic localization

Sudden deafness may occur with interruption of peripheral or central structures involved with hearing. It most commonly occurs with damage to the cochlea or eighth nerve. Cochlear or eighth nerve infarction may occur in isolation or with concomitant infarction of the labyrinth, brainstem, and cerebellum (92). Acute bilateral hearing impairment suggests vertebrobasilar occlusive disease (66; 98; 79), but hearing loss associated with vertebrobasilar insufficiency is most frequently unilateral (194). Viral infections, inflammatory conditions, or autoimmune disorders that produce sudden hearing loss generally involve the labyrinth or eighth nerve. Ménière syndrome involves the labyrinth. Tumors (eg, acoustic neuromas) and meningitis that produce sudden hearing loss generally involve the eighth nerve. The frequent spontaneous recovery of hearing loss, and improvement with steroid therapy, suggest that in many cases, a potentially reversible metabolic inner ear process disrupts the endocochlear potential rather than immediate hair-cell degeneration (167).

Pathophysiology

The pathophysiology of sudden deafness is poorly understood, and it is likely that a variety of pathophysiologies can all produce sudden deafness. Various theories have been proposed, including those attributing sudden deafness to vascular insults, infectious (especially viral) agents, autoimmune or inflammatory mechanisms, or disruption of labyrinthine membranes (92). Despite extensive investigation, most cases remain idiopathic. Of the non-idiopathic cases, vascular and infectious etiologies are probably the most common, and the pathophysiology of these is best understood.

In the 1950s, a series of important experimental studies in animals established that cochlear function is extremely sensitive to anoxia (43; 82; 83; 84; 85; 142; 141). Obstruction of either the inferior cochlear vein or the internal auditory artery produces rapid loss of function; electrical activity deteriorates within 60 seconds of interruption of blood flow. Cochlear function may return to normal if blood flow is restored within 8 minutes of complete obstruction but not if blood flow is interrupted for more than 30 minutes. External hair cells and the ganglion cells of the cochlea are particularly vulnerable to arterial obstruction, whereas the vestibular end organs are relatively resistant.

Venous drainage of the cochlea is via the vein of the cochlear aqueduct, which empties into the bulb of the jugular vein (10; 113). Venous obstruction produces early epithelial edema, followed by hemorrhage into the epithelium and perilymphatic and endolymphatic spaces, hair cell damage with secondary ganglion cell degeneration, and, later, fibrosis and ossification. Labyrinthine ischemia, attributed to impaired venous drainage, most commonly results from hyperviscosity syndromes (121; 153; 133; 08; 155). Increased blood viscosity produces obstruction in the labyrinthine venules and capillaries with decreased blood flow and ischemia of the inner ear, subsequent hemorrhage, and, later, fibrosis and ossification (82; 83). Similar changes occur in the eye, producing visual disturbances, markedly distended and tortuous ("sausage-shaped") retinal veins, and retinal hemorrhages.

Arterial obstruction produces more rapid and severe damage than venous obstruction, whereas arterial obstruction produces histologically evident changes in hair cells within 30 minutes, followed in a few hours by extensive necrosis, including the supporting cells without hemorrhage and, ultimately, severe fibrosis and ossification by 6 months. Several patterns of end-organ involvement occur with arterial obstruction and correspond to involvement of different arterial distributions within the inner ear.

The blood supply to the inner ear is via the internal auditory artery (also called the labyrinthine artery), which typically originates from the anterior inferior cerebellar artery (10; 112; 113). The internal auditory artery divides into two main branches within the internal auditory canal: (1) the common cochlear artery and (2) the anterior vestibular artery (10; 113). The common cochlear artery divides into the main cochlear artery and the vestibulocochlear artery, which together supply the cochlea (10; 113). The internal auditory artery and its branches are end arteries, so even transient ischemia can cause permanent inner ear damage. The organ of Corti is particularly sensitive to ischemia (158).

The anterior inferior cerebellar artery supplies the lateral pons, the middle cerebellar peduncle, the flocculus, the anterior part of the cerebellar lobules, and the inner ear (06). In patients with anterior inferior cerebellar artery territory infarction, the most consistently involved areas are the lateral pons and the middle cerebellar peduncle (06). As a result of the sharp angulation of the anterior inferior cerebellar artery at its origin, it is rarely occluded by emboli (186); rather, most occlusions are due to either basilar artery plaques extending into the anterior inferior cerebellar artery or microatheroma of its origin (07). Whether isolated or in combination with other symptoms and signs, deafness and vertigo can occur in anterior inferior cerebellar artery distribution infarctions due to involvement of several central and peripheral sites, which include the labyrinth, the eighth nerve, the vestibular nuclei, the vestibulocerebellum, or some combination.

Ramsay Hunt syndrome (herpes zoster oticus) is caused by the reactivation of herpes zoster virus that had been dormant in the seventh and eighth nerves following a previous infection with chicken pox. Pathologic findings in Ramsay Hunt syndrome include perivascular, perineural, and intraneural round-cell infiltration of the seventh and eighth nerves. A large number of other viruses have been associated with viral neurolabyrinthitis, but herpes simplex virus type 1 has been particularly associated with sudden sensorineural hearing loss (190; 145). Pathologic studies in patients with viral neurolabyrinthitis and sudden deafness have shown evidence of viral damage to the cochlea and auditory nerve, similar to that seen in patients with well-documented viral disorders (eg, mumps). Experimental animal studies have also demonstrated that several viruses can selectively infect the labyrinth and eighth nerve.

Genetic susceptibility may also be important in the pathogenesis of sudden deafness (25).

Differential diagnosis

Confusing conditions

Psychogenic sudden deafness can be identified by a discrepancy between behavioral hearing thresholds (eg, pure tone audiometry) and objective electrophysiologic examinations (eg, impedance audiometry, otoacoustic emissions, and brainstem auditory evoked responses) (13). Psychogenic sudden deafness can be unilateral or bilateral and generally ranges in severity from moderate hearing loss to profound hearing loss, with the majority having severe to profound hearing loss on pure-tone audiometry (13). It is most commonly reported in teenagers and young adults (13). Many have preexisting psychiatric illnesses or readily identified psychosocial stresses (13).

Associated or underlying disorders

Sudden hearing loss can be caused by a variety of disorders, including inner ear or eighth nerve ischemia, viral infection of the labyrinth or cochlear nerve, Ménière disease, intralabyrinthine membrane rupture, and autoimmune or inflammatory causes (172; 41; 182; 17; 108; 148; 61; 197; 92; 163). Uncommon causes include retrocochlear masses, demyelinating disease, syphilis, Lyme disease, Rickettsia felis infection, meningitis, carcinomatous meningitis, Takayasu arteritis, perilymph fistula, toxins, pregnancy, chronic sinusitis (especially in those aged 44 years or fewer), and prior radiation therapy for nasopharyngeal carcinoma (58; 60; 108; 73; 148; 136; 64; 77; 138; 21; 49; 92; 103; 131; 30; 68). Barotrauma, head injury (especially with temporal bone fracture, but also with inner ear concussion), and otologic surgery can also produce sudden hearing loss, but these are rare and fairly obvious causes (152; 99).

The putative cause is identified in about 10% to 15% of cases, and the remainder is almost always unilateral and considered idiopathic after evaluation (148; 51). Only a small minority (approximately 1%) has an identified retrocochlear cause (eg, vestibular schwannoma, demyelinating disease, stroke) (148; 59). Rare bilateral cases may be due to malingering, conversion disorders, and neurologic causes (eg, vertebrobasilar occlusive disease, carcinomatous meningitis, paraneoplastic syndromes, encephalitis, meningitis), and polysubstance abuse or overdose (87; 148; 161; 168).

A variety of conditions can cause inner ear ischemia, including thromboemboli of the posterior circulation (53), migraine (97; 143), fat emboli (72), thromboangiitis obliterans (86), hyperlipidemia (155), macroglobulinemia (153; 133), sickle cell disease (Morgenstern and Manace 1969; 08), leukemia (08); polycythemia vera (08); other causes of hypercoagulation or hyperviscosity (72; 08), and hypotension in otherwise healthy young adults (144). Inner ear infarction occurs most commonly in the setting of thromboembolic disease of the anterior inferior cerebellar artery or the basilar artery (54; 62; 134; 66; 80; 184; 175; 97). Sudden deafness in anterior inferior cerebellar artery infarction is often due to cochlea dysfunction from ischemia (97), but mixed central and peripheral vestibular dysfunction also occurs, making recognition of the components difficult. Anterior inferior cerebellar artery territory infarction can be confused with posterior inferior cerebellar artery territory infarction (Wallenberg syndrome) because of shared signs, including Horner syndrome, facial sensory impairment, vestibular signs, dysmetria, and contralateral impairment of pain and temperature sensation; however, severe facial paresis, hearing loss, and tinnitus are atypical for posterior inferior cerebellar artery territory infarctions (93), and their presence should alert the clinician to anterior inferior cerebellar artery territory infarction (06).

Various infectious disorders have been implicated in occasional cases of sudden hearing loss. A large number of viruses have been clinically, epidemiologically, or pathologically associated with hearing loss (65), but proof of viral etiology in individual cases is difficult to establish, with the exception of Ramsay Hunt syndrome, wherein the clinical features are fairly obvious and characteristic. Furthermore, the Henle-Koch postulates have not been satisfied for establishing a viral causation for sudden sensorineural hearing loss (115). Bacterial meningitis, syphilis, Lyme disease, and Rickettsia felis infection are among other infectious etiologies implicated in sudden hearing loss (138; 131). Rickettsia felis is an emergent pathogen belonging to the transitional group rickettsiae (140). First described in 1990, R felis infections can present with clinical signs similar to those of murine typhus and other febrile illnesses such as dengue fever, but like Lyme disease R felis infections can result in peripheral facial palsy and sudden deafness (138; 131). Cat fleas appear to be the most common vectors of R felis infections (140).

Although acoustic neuroma is a relatively rare cause of sudden hearing loss (less than 2% of patients with this problem) (41), sudden hearing loss may be the presenting symptom in 10% of patients to 15% of patients with acoustic neuroma (16; 41). These patients’ hearing may recover to normal levels with steroid therapy and may falsely suggest an inflammatory or immunologically mediated cause (16; 47). Other tumors can sometimes present with sudden hearing loss, and anecdotal reports include sudden hearing loss from a cochlear schwannoma (166). Sudden hearing loss may also complicate meningitis (40; 37), but it is rarely the presenting or only manifestation, except, in rare cases of chronic infectious, leukemic, or carcinomatous meningitis.

Sudden sensorineural hearing loss may also occur from medications, including nonsteroidal anti-inflammatory drugs (114), aminoglycosides, and phosphodiesterase inhibitors (14). Rapid ototoxic hearing loss is much more common in patients with poor renal function.

Sudden sensorineural hearing loss may be the initial presentation of Ménière disease, especially in patients with low-frequency hearing loss, or as a late manifestation years after onset (148). In those patients in whom sudden sensorineural hearing loss is the initial presentation, further fluctuation in hearing with attacks of vertigo is likely to develop within 3 years (148).

Sudden deafness can be an isolated symptom or the presenting symptom of a systemic disease.

Diagnostic workup

	• Initial evaluation of patients with presumptive sudden sensorineural hearing loss should include careful history and examination to identify bilateral sudden hearing loss, recurrent sudden hearing loss, or focal neurologic findings.
	• In addition, evaluation should identify likely toxic, otologic, or systemic causes, including evaluation of Lyme titers and syphilis serologies.
	• Audiograms should also be obtained to demonstrate the pattern and severity of hearing loss, which are helpful prognostically. It is important to distinguish sensorineural and conductive patterns of hearing loss in patients with sudden hearing loss. Audiograms should be obtained before and within 24 to 48 hours after initiation of treatment.
	• Patients with unilateral idiopathic sudden sensorineural hearing loss should be evaluated for retrocochlear pathology (eg, acoustic neuroma) using magnetic resonance imaging, brainstem auditory evoked potentials, or audiometric follow-up, whether or not apparent improvement or recovery is taking place (with or without steroid therapy).
	• As a result of a high rate of spontaneous recovery (approximately two thirds of cases), and because a large proportion of cases are ultimately considered to be idiopathic even after extensive evaluation, some have advocated a staged approach to diagnostic testing.

Initial evaluation of patients with presumptive sudden sensorineural hearing loss should include careful history and examination to identify bilateral sudden hearing loss, recurrent sudden hearing loss, or focal neurologic findings (170). In addition, evaluation should identify likely toxic, otologic, or systemic causes, including evaluation of Lyme titers and syphilis serologies. Audiograms should also be obtained to demonstrate the pattern and severity of hearing loss, which are helpful prognostically. It is important to distinguish sensorineural and conductive patterns of hearing loss in patients with sudden hearing loss (170). Audiograms should be obtained before and within 24 to 48 hours after initiation of treatment. Clinical practice guidelines specify that follow-up audiometric evaluation should be obtained within 6 months of diagnosis (170), and others suggest serial audiograms over the course of a year (eg, at 2, 6, and 12 months after onset) (148).

Patients with unilateral idiopathic sudden sensorineural hearing loss should be evaluated for retrocochlear pathology (eg, acoustic neuroma) using magnetic resonance imaging, brainstem auditory evoked potentials, or audiometric follow-up (170), whether or not apparent improvement or recovery is taking place (with or without steroid therapy) (162; 187; 01; 139; 147; 148). Cranial imaging is also important to exclude brainstem or cerebellar lesions (eg, vestibular schwannoma) (187; 01; 202), and MRI may identify a number of other pathologies (eg, vascular abnormalities, demyelination, hydrops, mastoiditis) (160; 01; 147; 202), but MRI does not visualize the inner ear well enough to reliably identify infarction and is insensitive for abnormalities (eg, enhancement) associated with cochleitis or labyrinthitis (173; 160). Inner ear MRI after intravenous gadolinium injection identifies abnormalities related to hearing in only about a quarter of cases (202). Approximately half of practicing otolaryngologists routinely utilize MRI in evaluating patients with sudden sensorineural hearing loss (31), and many neurologists routinely use this technology in the initial evaluation of patients with sudden sensorineural hearing loss, despite a low yield of identified retrocochlear pathology, because of medicolegal concerns (74). Guidelines recommend against use of CT of the head and brain in the initial evaluation of patients with sudden sensorineural hearing loss (170), although in patients who cannot have an MRI, CT and brainstem auditory evoked potential studies should be considered, though these are less sensitive than MRI for detection of retrocochlear pathology (148).

As a result of a high rate of spontaneous recovery (approximately two thirds of cases), and because a large proportion of cases are ultimately considered to be idiopathic even after extensive evaluation, some have advocated a staged approach to diagnostic testing (34; 92). Patients with likely systemic causes or clinically evident neurologic abnormalities should have diagnostic testing without delay. In patients without other clinical findings, further diagnostic evaluation can possibly be delayed for a month to see if spontaneous improvement occurs. Note, though, that improvement with steroids (in the absence of MRI or brainstem auditory evoked responses) can result in failure to identify important clinical conditions, including acoustic neuroma. If improvement does not occur or if other symptoms or signs develop, more extensive diagnostic testing is indicated and should include cranial imaging with magnetic resonance imaging.

Additional diagnostic studies can include imaging of cerebral vessels, brainstem auditory evoked potentials, electronystagmography with bithermal caloric irrigation, vestibular-evoked myogenic potentials, lumbar puncture, and various blood studies. Brainstem auditory evoked potentials may show absence of wave I or all waveforms but may also show absence of wave I with delay of wave III and wave V, if dysfunction is also occurring in the retrocochlear eighth nerve and brainstem auditory nuclei and pathways (184). Electronystagmography or videonystagmography with bithermal caloric testing may demonstrate ipsilateral horizontal canal paresis. Vestibular-evoked myogenic potential studies may show an absence of response on the affected side, supporting labyrinthine damage, particularly in patients with associated vertigo (71; 146). Lumbar puncture should be performed (after cranial imaging) in immunocompromised patients and those with suspected chronic meningitis. In cases of clinically suspected sudden hearing loss resulting from hyperviscosity, the following blood studies can be considered: serum viscosity determination, complete blood count, syphilis serologies, sedimentation rate, serum protein, serum protein electrophoresis, and lipid studies. In cases of clinically suspected autoimmune inner ear disease, the following blood studies can be considered: sedimentation rate, rheumatoid factor, antinuclear antibody assay, antineutrophil cytoplasmic antibody assay, circulating immune complex levels, and urinalysis. Moreover, a number of more sophisticated immunologic tests of serological or cell-mediated reactivity to homologous and heterologous inner ear antigen extracts may have some utility but are not routinely available (57). Antibodies to a 68 kD heat shock protein (anti-hsp70) are not helpful (157). No correlation has been demonstrated between antibodies to inner ear antigens in patients with presumed autoimmune hearing loss and cochlear enhancement on MRI (200).

Management

	• Management is complicated because the underlying etiology is not known in most patients.
	• A presumptive approach is generally employed, but no consensus exists concerning the management of sudden hearing loss.
	• Clinicians should not routinely prescribe antivirals, thrombolytics, vasodilators, vasoactive substances, or antioxidants to patients with idiopathic sudden sensorineural hearing loss.
	• "Shotgun" approaches employing a battery of simultaneously administered treatments directed at common potential causes of sudden hearing loss are discouraged.
	• The efficacy of antiviral agents, anticoagulants, vasodilators, rheologic agents, free radical scavengers, ginkgo products, and other drugs is unproved in patients with idiopathic sudden hearing loss.
	• Systemic corticosteroids, or a combination of systemic and intratympanic steroids, have been considered the “current standard treatment” and had been thought to be modestly effective in treating idiopathic sudden hearing loss.
	• Some authorities recommend intratympanic dexamethasone only for subsequent or salvage treatment of idiopathic sudden sensorineural hearing loss.

Management is complicated as the underlying etiology is not known in most patients. A presumptive approach is generally employed, but no consensus exists concerning the management of sudden hearing loss (55; 31). Because of the lack of consensus, significant differences exist across specialists in the treatment of sudden sensorineural hearing loss (31).

Clinicians should not routinely prescribe antivirals, thrombolytics, vasodilators, vasoactive substances, or antioxidants to patients with idiopathic sudden sensorineural hearing loss (170). "Shotgun" approaches employing a battery of simultaneously administered treatments directed at common potential causes of sudden hearing loss are discouraged. The efficacy of antiviral agents, anticoagulants, vasodilators, rheologic agents, free radical scavengers, ginkgo products, and other drugs is unproved in patients with idiopathic sudden hearing loss (75; 33; 148; 170); most studies have been uncontrolled trials, and results are not clearly different than the natural history of this condition. Surgery is rarely indicated, except possibly in cases where clear evidence of perilymphatic fistula exists or to manage associated problems (eg, facial palsy in Ramsay Hunt syndrome).

Systemic corticosteroids, or a combination of systemic and intratympanic steroids, have been considered the “current standard treatment” and had been thought to be modestly effective in treating idiopathic sudden hearing loss (191; 122; 55; 41; 03; 110; 167; 32; 33; 148; 31; 137; 149; 169; 52; 135; 101; 176; 88). Steroids have also been used in patients with sudden hearing loss and known recent viral infections, autoimmune disease (eg, Crohn disease or ulcerative colitis), or meningitis (40; 11). Most of the reported benefit of steroids was within the first 1 to 2 weeks after onset, which is also the typical timeframe for spontaneous recovery, and little, if any, benefit could be expected if initiated 4 weeks or longer after onset (148). Unfortunately, available trials of corticosteroids for sudden hearing loss are generally of poor quality and have shown inconsistent and contradictory results (188; 35). Systematic syntheses and meta-analyses have failed to support the use of corticosteroids for sudden deafness and, instead, have concluded that “systemic or intratympanic steroid administration does not have a significant treatment effect” (188; 35; 67).

An international panel of experts at the IFOS 2017 ENT World Congress in Paris, France, reached a consensus that acknowledged the lack of evidence supporting steroid use, but nevertheless, the panel concluded that it was the current standard of care: “Although evidence of the efficacy of systemic steroids cannot be considered as strong enough to recommend their use, it is still the most widespread primary therapy and can be considered as the current standard of care” (109).

Some randomized trials found no difference in the rate of hearing improvement between systemic, intratympanic, and combined corticosteroid therapy for sudden hearing loss (09; 181). In a nonrandomized retrospective series of primary treatment of sudden hearing loss, in which the level of hearing loss is 70 to 89 dB HL, the addition of intratympanic steroids to the treatment significantly increased the success rate (38). In another nonrandomized retrospective case series, there was no significant difference in hearing outcomes between the 4-injection (on days 1, 2, 4, and 7) and 2-injection (on days 1 and 2) groups receiving intratympanic steroids for the primary treatment of sudden hearing loss (179).

Some authorities recommend intratympanic dexamethasone only for subsequent or salvage treatment of idiopathic sudden sensorineural hearing loss (137; 48; 135; 88). Indeed, based on a systematic review of available studies, intratympanic corticosteroid therapy has been prescribed primarily when there is a failure of conventional therapy and when systemic corticosteroids may aggravate comorbid illness, such as with diabetic patients (15). Steroids for salvage treatment of patients failing traditional therapy may have a beneficial treatment effect in a meta-analysis of available trials, although this is only a tentative conclusion because of the poor quality of component trials (35). If administered, intratympanic steroids should be administered within 6 weeks of onset of hearing loss and should be reserved for patients with at least severe sensorineural hearing loss (ie, pure-tone average greater than 50 dB and speech discrimination less than 50%) (110) or as “salvage therapy” for patients who do not improve with oral corticosteroids (02; 148; 31; 192). According to clinical practice guidelines, intratympanic steroid perfusion should be offered in patients with incomplete recovery from idiopathic sudden sensorineural hearing loss after failure of initial management (170), and when used as salvage therapy, intratympanic steroids can result in significant gains in hearing (192).

Adding low molecular weight dextran to oral corticosteroids is not associated with greater hearing gain or better hearing outcome in patients with idiopathic sudden sensorineural hearing loss (185), although a benefit is claimed for dextran infusion in the peripartum period based on case series data (201). Before this treatment is considered, a well-designed randomized controlled trial showing clear benefit is needed.

In preliminary studies, topically applied recombinant human insulin-like growth factor 1 (IGF1) using gelatin hydrogels was associated with a significant improvement in pure-tone thresholds in patients considered refractory to systemic steroids (128; 127; 130). The major effects of this salvage therapy are thought to occur in the first 4 weeks after treatment.

Hyperbaric oxygen therapy (HBOT) is an option within 3 months of diagnosis of idiopathic sudden sensorineural hearing loss, though its effectiveness remains possible but unproven (04; 63; 170; 36; 164; 05; 28; 193; 22). A matched control retrospective case series demonstrated no significant difference in hearing outcomes between patients receiving salvage therapy with HBOT and intratympanic steroids compared to patients receiving intratympanic steroids alone (05). Another case series suggested that HBOT is a safe and beneficial adjuvant therapy for patients with idiopathic sudden sensorineural hearing loss (193). In contrast, a prospective randomized trial in 60 affected soldiers with idiopathic sudden sensorineural hearing loss found that hearing recovery on day 180 was significantly better in those who received the conventional treatment plus HBOT (28). A short delay to HBOT, more severe hearing loss at presentation, and younger age are the best predictive factors of improved hearing loss (164). However, these are exactly what would be expected as indications of greater spontaneous recovery. In a randomized trial of 171 patients with sudden sensorineural hearing loss randomly assigned to HBOT, oral steroids, or both, HBOT was the most efficacious treatment when started within 7 days from sudden sensorineural hearing loss onset, while HBOT plus oral steroids was most efficacious when treatment was started more than 14 days from symptom onset (22). Outcome of HBOT is poor if treatment is delayed over 28 days (164). Further well-designed randomized controlled trials are needed to clarify the role of HBOTs.

Patients with identified etiologies for sudden sensorineural hearing loss may require targeted specific therapies. For example, patients with Ramsay Hunt syndrome should be treated with acyclovir (1 gm daily for 10 days), but available data do not suggest a benefit of antiviral agents in clinically diagnosed viral neurolabyrinthitis (174). Anecdotal evidence suggests that infliximab may be helpful in some cases of sudden deafness due to autoimmune inner ear disease (61). In addition, psychotherapy has been employed successfully in some patients with psychogenic sudden deafness (13).

N-acetyl-cysteine, which has been claimed to have antioxidant effects, has been reported to potentially be beneficial as a treatment for sudden hearing loss (24), but this needs to be confirmed with a well-designed double-blind, randomized controlled trial.

In diabetics, control of blood glucose level during treatment of sudden deafness does not directly affect prognosis (120).

Associated vertigo and the concomitant nausea and vomiting should be treated symptomatically with medications; vestibular rehabilitation should be begun early (91). For those who do not recover from idiopathic sudden deafness in their only hearing ear (ie, producing bilateral deafness), cochlear implantation can be considered as early as 3 months after initiating treatment of sudden deafness (102). Cochlear implantation in unilateral sudden hearing loss with a normal functioning contralateral ear may also prove to be an effective therapy (18). Available data suggest that subjective tinnitus, speech discrimination, sound localization, and speech comprehension are improved by cochlear implantation in selected patients.

A multidisciplinary rehabilitation approach involving audiological may be necessary to help patients cope with the complex issues associated with sudden deafness (20). Personalized psychological interventions and pharmacological therapy may be helpful in managing anxiety and depression associated with sudden deafness (177).

References

01: Aarnisalo AA, Suoranta H, Ylikoski J. Magnetic resonance imaging findings in the auditory pathway of patients with sudden deafness. Otol Neurotol 2004;25:245-9. PMID 15129100
02: Ahn JH, Han MW, Kim JH, Chung JW, Yoon TH. Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Otolaryngol 2008a;128:128-31. PMID 17851916
03: Alexiou C, Arnold W, Fausner C, et al. Sudden sensorineural hearing loss: does application of glucocorticoids make sense. Arch Otolaryngol Head Neck Surg 2001;127:253-8. PMID 11255468
04: Alimoglu Y, Inci E, Edizer DT, Ozdilek A, Aslan M. Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases. Eur Arch Otorhinolaryngol 2011;268(12):1735-41. PMID 21431435
05: Almosnino G, Holm JR, Schwartz SR, Zeitler DM. The role of hyperbaric oxygen as salvage therapy for sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 2018;127(10):672-6. PMID 30009614
06: Amarenco P, Hauw JJ. Cerebellar infarction in the territory of the anterior and inferior cerebellar artery: a clinicopathologic study of 20 cases. Brain 1990;113:139-55. PMID 2302529
07: Amarenco P, Rosengart A, DeWitt LD, Pessin MS, Caplan LR. Anterior inferior cerebellar artery territory infarcts: mechanisms and clinical features. Arch Neurol 1993;50:154-61. PMID 8431134
08: Andrews JC, Hoover LA, Lee RS, Honrubia V. Vertigo in the hyperviscosity syndrome. Otolaryngol Head Neck Surg 1988;98:144-9. PMID 3128757
09: Ashtiani MK, Firouzi F, Bastaninejad S, et al. Efficacy of systemic and intratympanic corticosteroid combination therapy versus intratympanic or systemic therapy in patients with idiopathic sudden sensorineural hearing loss: a randomized controlled trial. Eur Arch Otorhinolaryngol 2018;275(1):89-97. PMID 29149379
10: Axelsson A. The vascular anatomy of the cochlea in the guinea pig and in man. Acta Otolaryngologica 1968;(Suppl):243:1-134. PMID 5754509
11: Bachmeyer C, Leclerc-Landgraf N, Laurette F, et al. Acute autoimmune sensorineural hearing loss associated with Crohn's disease. Am J Gastroenterol 1998;93:2565-7. PMID 9860428
12: Bahls FH, Chatrian GE, Mesher RA, Sumi SM, Ruff RL. A case of persistent cortical deafness: clinical, neurophysiologic, and neuropathologic observations. Neurology 1988;38:1490-3. PMID 3412601
13: Ban JH, Jin SM. A clinical analysis of psychogenic sudden deafness. Otolaryngol Head Neck Surg 2006;134:970-4. PMID 16730540
14: Barreto MA, Bahmad F Jr. Phosphodiesterase type 5 inhibitors and sudden sensorineural hearing loss. Braz J Otorhinolaryngol 2013;79(6):727-33. PMID 24474485
15: Barreto MA, Ledesma AL, de Oliveira CA, Bahmad F Jr. Intratympanic corticosteroid for sudden hearing loss: does it really work? Braz J Otorhinolaryngol 2016;82(3):353-64. PMID 26873148
16: Berenholz LP, Eriksen C, Hirsch FA. Recovery from repeated sudden hearing loss with corticosteroid use in the presence of an acoustic neuroma. Ann Otol Rhinol Laryngol 1992;101:827-31. PMID 1416637
17: Berrocal JR, Ramirez-Camacho R. Sudden sensorineural hearing loss: supporting the immunologic theory. Ann Otol Rhinol Laryngol 2002;111:989-97. PMID 12450172
18: Blasco MA, Redleaf MI. Cochlear implantation in unilateral sudden deafness improves tinnitus and speech comprehension: meta-analysis and systematic review. Otol Neurotol 2014;35(8):1426-32. PMID 24786540
19: Cao Z, Li Z, Xiang H, et al. Prognostic role of haematological indices in sudden sensorineural hearing loss: Review and meta-analysis. Clin Chim Acta 2018;483:104-11. PMID 29684383
20: Carlsson PI, Hall M, Lind KJ, Danermark B. Quality of life, psychosocial consequences, and audiological rehabilitation after sudden sensorineural hearing loss. Int J Audiol 2011;50(2):139-44. PMID 21265640
21: Cassilde AL, Barnaud G, Baccar S, Mortier E. Sudden-onset bilateral deafness revealing early neurosyphilis. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131(6):389-91. PMID 24880727
22: Cavaliere M, De Luca P, Scarpa A, et al. Combination of hyperbaric oxygen therapy and oral steroids for the treatment of sudden sensorineural hearing loss: early or late? Medicina (Kaunas) 2022;58(10):1421. PMID 36295581
23: Chang TP, Wang Z, Winnick AA, et al. Sudden hearing loss with vertigo portends greater stroke risk than sudden hearing loss or vertigo alone. J Stroke Cerebrovasc Dis 2018;27(2):472-8. PMID 29102540
24: Chen CH, Young YH. N-acetylcysteine as a single therapy for sudden deafness. Acta Otolaryngol 2017;137(1):58-62. PMID 27553486
25: Chen K, Sun L, Zong L, et al. GJB2 and mitochondrial 12S rRNA susceptibility mutations in sudden deafness. Eur Arch Otorhinolaryngol 2016;273(6):1393-8. PMID 26119842
26: Chen L, Zhang G, Zhang Z, Wang Y, Hu L, Wu J. Neutrophil-to-lymphocyte ratio predicts diagnosis and prognosis of idiopathic sudden sensorineural hearing loss: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97(38):e12492. PMID 30235752
27: Cheng YF, Xirasagar S, Chen CS, Niu DM, Lin HC. Association of Fabry disease with hearing loss, tinnitus, and sudden hearing loss: a nationwide population-based study. J Clin Med 2022;11(24):7396. PMID 36556012
28: Chi TH, Chiang MC, Chen RF, Yuan CH. Does the addition of hyperbaric oxygen therapy to conventional treatment modalities influence the outcome of soldiers with idiopathic sudden sensorineural hearing loss? J R Army Med Corps 2018;164(2):69-71. PMID 29431146
29: Cho TY, Cheng PW, Young YH. Secondary endolymphatic hydrops after sudden deafness. Acta Otolaryngol 2013;133(10):1040-6. PMID 24032569
30: Cho TY, Cheng PW, Young YH. Evolution of postirradiated sudden deafness in nasopharyngeal carcinoma survivors during the past two decades. Laryngoscope 2016;126(9):2016-21. PMID 26864918
31: Coelho DH, Thacker LR, Hsu DW. Variability in the management of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2011;145(5):813-7. PMID 21690271
32: Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: I. A systematic review. Arch Otolaryngol Head Neck Surg 2007a;133:573-81. PMID 17576908
33: Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: II. A meta-analysis. Arch Otolaryngol Head Neck Surg 2007b;133:582-6. PMID 17576909
34: Cowan PF, Chow JM. Sudden sensorineural hearing loss. Am Fam Physician 1988;37:207-10. PMID 3348121
35: Crane RA, Camilon M, Nguyen S, Meyer TA. Steroids for treatment of sudden sensorineural hearing loss: a meta-analysis of randomized controlled trials. Laryngoscope 2015;125(1):209-17. PMID 25045896
36: Cvorovic L, Jovanovic MB, Milutinovic Z, Arsovic N, Djeric D. Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss. Otol Neurotol 2013;34(6):1021-6. PMID 23820795
37: Damodaran A, Aneja S, Malhotra VL, et al. Sensorineural hearing loss following acute bacterial meningitis - a prospective evaluation. Indian Pediatr 1996;33:763-6. PMID 9057404
38: Demirhan H, Gökduman AR, Hamit B, Yürekli Altındağ MF, Yiğit Ö. Contribution of intratympanic steroids in the primary treatment of sudden hearing loss. Acta Otolaryngol 2018;138(7):648-51. PMID 29513064
39: Deng Y, Shi J, Zhang M, Qi X. Clinical characteristics of cerebral hemorrhage with bilateral sudden deafness as the first symptom. Neurol Sci 2021;42(1):141-50. PMID 32556747
40: Eden AR, Cummings FR. Sudden bilateral hearing loss and meningitis in adults. J Otolaryngol 1978;7:304-9. PMID 691097
41: Eisenman DJ, Arts HA. Effectiveness of treatment for sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2000;126:1161-4. PMID 10979137
42: Ferbert A, Bruckman H, Drummen R. Clinical features of proven basilar artery occlusion. Stroke 1990;21:1135-42. PMID 2389292
43: Fernandez C. The effect of oxygen lack on cochlear potentials. Ann Otol Rhinol Laryngol 1955;64:1193-203. PMID 13283493
44: Fetterman BL, Saunders JE, Luxford WM. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 1996;17:529-36. PMID 8841697
45: Fife TD, Baloh RW, Duckwiler GR. Isolated dizziness in vertebrobasilar insufficiency: clinical features, angiography, and follow-up. J Stroke Cerebrovasc Dis 1994;4:4-12. PMID 26487528
46: Fisher CM. Vertigo in cerebrovascular disease. Arch Otolaryngol 1967;85:529-34. PMID 6023709
47: Gaffney RJ, McShane DP. Bilateral acoustic neurofibromatosis camouflaged by corticosteroid treatment of sudden sensorineural hearing loss. Ir J Med Sci 1996;165:151-2. PMID 8824013
48: Garavello W, Galluzzi F, Gaini RM, Zanetti D. Intratympanic steroid treatment for sudden deafness: a meta-analysis of randomized controlled trials. Otol Neurotol 2012;33(5):724-9. PMID 22699982
49: Goel A, Sharma S, Aneja S. Sudden onset permanent deafness as an early complication of bacterial meningitis. Indian J Pediatr 2014;81(6):625. PMID 23783768
50: Gomez CR, Cruz-Flores S, Malkoff MD, Sauer CM, Burch CM. Isolated vertigo as a manifestation of vertebrobasilar ischemia. Neurology 1996;47:94-7. PMID 8710132
51: Greco A, Fusconi M, Gallo A, Marinelli C, Macri GF, De Vincentiis M. Sudden sensorineural hearing loss: an autoimmune disease. Autoimmun Rev. 2011;10(12):756-61. PMID 21619944
52: Gundogan O, Pinar E, Imre A, Ozturkcan S, Cokmez O, Yigiter AC. Therapeutic efficacy of the combination of intratympanic methylprednisolone and oral steroid for idiopathic sudden deafness. Otolaryngol Head Neck Surg 2013;149(5):753-8. PMID 23959817
53: Gur C, Lalazar G, Raphaeli G, Gilon D, Ben-Chetrit E. Mitral stenosis presenting with acute hearing loss. PLoS Med 2006;3(6):e233. PMID 16768545
54: Gussen R. Sudden deafness of vascular origin: a human temporal bone study. Ann Otol 1976;85:94-100. PMID 1259320
55: Haberkamp TJ, Tanyeri HM. Management of idiopathic sudden sensorineural hearing loss. Am J Otol 1999;20:587-92. PMID 10503580
56: Harada T. Patterns of hearing recovery in idiopathic sudden sensorineural hearing loss. Br J Audiol 1996;30:363-7. PMID 8985560
57: Harris JP, O'Driscoll K. Autoimmune inner ear disease. In: Baloh RW, Halmagyi GM. Disorders of the vestibular system. New York: Oxford University Press, 1996:374-80.
58: Healy DG, Wood NW. Clinical picture of bilateral vestibular schwannomas, sudden bilateral hearing loss, and aviation. Neurology 2004;62:933. PMID 15365156
59: Hellmann MA, Steiner I, Mosberg-Galili R. Sudden sensorineural hearing loss in multiple sclerosis: clinical course and possible pathogenesis. Acta Neurol Scand 2011;124(4):245-9. PMID 21198448
60: Hengstman GJD, Schelhaas HJ, Zwarts MJ. Auditory dysfunction in chronic inflammatory demyelinating polyradiculopathy. Neurology 2004;62:1446-8. PMID 15111702
61: Heywood RL, Hadavi S, Donnelly S, Patel N. Infliximab for autoimmune inner ear disease: case report and literature review. J Laryngol Otol 2013;127(11):1145-7. PMID 24125068
62: Hinojosa R, Kohut RI. Clinical diagnosis of anterior inferior cerebellar artery thrombosis: autopsy and temporal bone histopathologic study. Ann Otol Rhinol Laryngol 1990;99:261-72. PMID 2327695
63: Holy R, Navara M, Dosel P, Fundova P, Prazenica P, Hahn A. Hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss (ISSNHL) in association with combined treatment. Undersea Hyperb Med 2011;38(2):137-42. PMID 21510273
64: Hou ZQ, Wang QJ. A new disease: pregnancy-induced sudden sensorineural hearing loss. Acta Otolaryngol 2011;131(7):779-86. PMID 21426273
65: Huang CC, Lin WB, Chang PH, Chan KC, Lee TJ. Sudden deafness as a presenting symptom of chronic hepatitis B with acute exacerbation. Otolaryngol Head Neck Surg 2009;141(5):659-60. PMID 19861211
66: Huang MH, Huang CC, Ryu SJ, Chu NS. Sudden bilateral hearing impairment in vertebrobasilar occlusive disease. Stroke 1993;24:132-7. PMID 8418537
67: Hultcrantz E, Nosrati-Zarenoe R. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: analysis of an RCT and material drawn from the Swedish national database. Eur Arch Otorhinolaryngol 2015;272(11):3169-75. PMID 25351498
68: Hung SH, Lin HC, Kao LT, Wu CS, Chung SD. Sudden sensorineural hearing loss is associated with chronic rhinosinusitis: population-based study. J Laryngol Otol 2016;130(6):521-5. PMID 27117586
69: Hyden D. Mumps labyrinthitis, endolymphatic hydrops and sudden deafness in succession in the same ear. ORL J Otorhinolaryngol Relat Spec 1996;58:338-42. PMID 8958544
70: Ishida IM, Sugiura M, Teranishi M, Katayama N, Nakashima T. Otoacoustic emissions, ear fullness and tinnitus in the recovery course of sudden deafness. Auris Nasus Larynx 2008;35:41-6. PMID 17904320
71: Iwasaki S, Takai Y, Ozeki H, Ito K, Karino S, Murofushi T. Extent of lesions in idiopathic sudden hearing loss with vertigo: study using click and galvanic vestibular evoked myogenic potentials. Arch Otolaryngol Head Neck Surg 2005;131:857-62. PMID 16230586
72: Jaffe BF. Sudden deafness - a local manifestation of systemic disorders: fat emboli, hypercoagulation and infections. Laryngoscope 1970;80:788-801. PMID 5452517
73: Jeffs GJ, Lee GY, Wong GT. Leptomeningeal carcinomatosis: an unusual cause of sudden onset bilateral sensorineural hearing loss. J Clin Neurosci 2006;13:116-8. PMID 16410210
74: Jiang ZY, Mhoon E, Saadia-Redleaf M. Medicolegal concerns among neurotologists in ordering MRIs for idiopathic sensorineural hearing loss and asymmetric sensorineural hearing loss. Otol Neurotol 2011;32(3):403-5. PMID 21358454
75: Kanzaki J, Inoue Y, Ogawa K, et al. Effect of single-drug treatment on idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2003;30(2):123-7. PMID 12753981
76: Karlberg M, Halmagyi GM, Buttner U, Yavor RA. Sudden unilateral hearing loss with simultaneous ipsilateral posterior semicircular canal benign paroxysmal positional vertigo: a variant of vestibulo-cochlear neurolabyrinthitis. Arch Otolaryngol Head Neck Surg 2000;126:1024-9. PMID 10922239
77: Kenny R, Patil N, Considine N. Sudden (reversible) sensorineural hearing loss in pregnancy. Ir J Med Sci 2011;180(1):79-84. PMID 20665123
78: Kikidis D, Nikolopoulos TP, Kampessis G, Stamatiou G, Chrysovergis A. Sudden sensorineural hearing loss: subclinical viral and toxoplasmosis infections as aetiology and how they alter the clinical course. ORL J Otorhinolaryngol Relat Spec 2011;73(2):110-5. PMID 21389742
79: Kim E, Son MK, Kang CK, Lee YB. Vertebrobasilar occlusion presenting as sudden isolated bilateral sensorineural hearing loss: case report. J Cerebrovasc Endovasc Neurosurg 2013;15(3):225-8. PMID 24167804
80: Kim JS, Lopez I, DiPatre PL, et al. Internal auditory artery infarction: clinicopathologic correlation. Neurology 1999;52:40-4. PMID 9921846
81: Kim JY, Han JJ, Sunwoo WS, et al. Sudden sensorineural hearing loss in children and adolescents: Clinical characteristics and age-related prognosis. Auris Nasus Larynx 2018;45(3):447-55. PMID 28888426
82: Kimura R, Perlman HB. Extensive venous obstruction of the labyrinth. A. Cochlear changes. Ann Otol Rhinol Laryngol 1956a;61:332-51. PMID 13355160
83: Kimura R, Perlman HB. Extensive venous obstruction of the labyrinth. B. Vestibular changes. Ann Otol Rhinol Laryngol 1956b;61:332-51. PMID 13363222
84: Kimura R, Perlman HB. Arterial obstruction of the labyrinth: part I. cochlear changes. Ann Otol Rhinol Laryngol 1958a;67:5-24. PMID 13521620
85: Kimura R, Perlman HB. Arterial obstruction of the labyrinth: part II. vestibular changes. Ann Otol Rhinol Laryngol 1958b;67:25-40. PMID 13521621
86: Kirikae I, Nomura Y, Shitara T, Kobayashi T. Sudden deafness due to Buerger's disease. Arch Otolaryngol 1962;75:502-5. PMID 14456277
87: Koda H, Kimura Y, Iino Y, Eishi Y, Murakami Y, Kitamura K. Bilateral sudden deafness caused by diffuse metastatic leptomeningeal carcinomatosis. Otol Neurotol 2008;29:727-9. PMID 18451746
88: Kordis S, Vozel D, Hribar M, Urbančič NB, Battelino S. The outcome of prompt concomitant single-dose high-concentration intratympanic and tapered low-dose oral systemic corticosteroid treatment for sudden deafness. J Int Adv Otol 2020;16(2):201-6. PMID 32784158
89: Korres S, Stamatiou GA, Gkoritsa E, Riga M, Xenelis J. Prognosis of patients with idiopathic sudden hearing loss: role of vestibular assessment. J Laryngol Otol 2011;125(3):251-7. PMID 21054906
90: Lammers MJW, Young E, Westerberg BD, Lea J. Risk of stroke and myocardial infarction after sudden sensorineural hearing loss: a meta-analysis. Laryngoscope 2021;131(6):1369-77. PMID 33156954
91: Lanska DJ. Vertigo and other forms of dizziness. In: Corey-Bloom J, editor. Adult neurology. 2nd edition. Oxford, England: Blackwell Publishing Ltd., 2005:85-101.**
92: Lanska DJ. Disorders of the special senses in the elderly. In: Nair A, Sabbagh M, editors. Geriatric neurology. Chichester, West Sussex, UK: John Wiley & Sons, 2014:396-459.
93: Lee H. Sudden deafness related to posterior circulation infarction in the territory of the nonanterior inferior cerebellar artery: frequency, origin, and vascular topographical pattern. Eur Neurol 2008;59:302-6. PMID 18408371
94: Lee H, Ahn BH, Baloh RW. Sudden deafness with vertigo as a sole manifestation of anterior inferior cerebellar artery infarction. J Neurol Sci 2004;222:105-7. PMID 15240204
95: Lee H, Baloh RW. Sudden deafness in vertebrobasilar ischemia: clinical features, vascular topographical patterns and long-term outcome. J Neurol Sci 2005;228:99-104. PMID 15607217
96: Lee H, Cho YW. Auditory disturbance as a prodrome of anterior inferior cerebellar artery infarction. J Neurol Neurosurg Psychiatry 2004;74:1644-8. PMID 14638883
97: Lee H, Sohn SI, Jung DK, et al. Sudden deafness and anterior inferior cerebellar artery infarction. Stroke 2002;33:2807-12. PMID 12468774
98: Lee H, Whitman GT, Lim JG, Lee SD, Park YC. Bilateral sudden deafness as a prodrome of anterior inferior cerebellar artery infarction. Arch Neurol 2001;58:1287-9. PMID 11493170
99: Lee EJ, Yang YS, Yoon YJ. Case of bilateral pneumolabyrinth presenting as sudden, bilateral deafness, without temporal bone fracture, after a fall. J Laryngol Otol 2012;126(7):717-20. PMID 22583781
100: Lee H, Yi HA, Baloh RW. Sudden bilateral simultaneous deafness with vertigo as a sole manifestation of vertebrobasilar insufficiency. J Neurol Neurosurg Psychiatry 2003;74:539-41. PMID 12640087
101: Lee HY, Kim DK, Park YH, Cha WW, Kim GJ, Lee SH. Prognostic factors for profound sudden idiopathic sensorineural hearing loss: a multicenter retrospective study. Eur Arch Otorhinolaryngol 2017;274(1):143-9. PMID 27544193
102: Lee SS, Cho HH, Jang CH, Cho YB. Fate of sudden deafness occurring in the only hearing ear: outcomes and timing to consider cochlear implantation. J Korean Med Sci 2010;25(2):283-6. PMID 20119584
103: Leite HF, Leite Jda C, Melo MH, Vasconcelos CC, Alvarenga RM. Deafness in patients with multiple sclerosis. Audiol Neurootol 2014;19(4):261-6. PMID 25170548
104: Leussink V, Andermann P, Reiners K, Shehata-Dieter W, Gunther-Lengsfeld T, Naumann M. Sudden deafness from stroke. Neurology 2005;64:1817-8. PMID 15911827
105: Li BL, Xu JY, Lin S. Sudden deafness as a prodrome of cerebellar artery infarction: Three case reports. World J Clin Cases 2022;10(15):4895-903. PMID 35801026
106: Lin HC, Chao PZ, Lee HC. Sudden sensorineural hearing loss increases the risk of stroke: a 5-year follow-up study. Stroke 2008;39:2744-8. PMID 18583554
107: Lin RJ, Krall R, Westerberg BD, Chadha NK, Chau JK. Systematic review and meta-analysis of the risk factors for sudden sensorineural hearing loss in adults. Laryngoscope 2012;122(3):624-35. PMID 22252719
108: Maruyoshi H, Toyama K, Kojima S, et al. Sensorineural hearing loss combined with Takayasu’s arteritis. Intern Med 2005;44:124-8. PMID 15750272
109: Marx M, Younes E, Chandrasekhar SS, et al. International consensus (ICON) on treatment of sudden sensorineural hearing loss. Eur Ann Otorhinolaryngol Head Neck Dis 2018;135(1S):S23-8. PMID 29396226
110: Marzo SJ. Intratympanic steroid perfusion for sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2005;131:730-2. PMID 16103308
111: Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463-80. PMID 889223
112: Mazzoni A. Internal auditory canal arterial relations at the porus acusticus. Ann Otol Rhinol Laryngol 1969;78:797-814. PMID 5799404
113: Mazzoni A. The vascular anatomy of the vestibular labyrinth in man. Acta Otolaryngologica 1990;472:1-83. PMID 2239254
114: McKinnon BJ, Lassen LF. Naproxen-associated sudden sensorineural hearing loss. Mil Med 1998;163:792-3. PMID 9819544
115: Merchant SN, Durand ML, Adams JC. Sudden deafness: is it viral. ORL J Otorhinolaryngol Relat Spec 2008;70:52-60. PMID 18235206
116: Millikan C. Neurology: its role in ophthalmology and otolaryngology. Trans Am Acad Ophthalmol Otolaryngol 1964;68:208-17. PMID 14130928
117: Millikan C, Futrell N. Occlusion of the internal auditory artery. Ann Neurol 1990a;28:258.
118: Millikan C, Futrell N. Vertigo of vascular origin. Arch Neurol 1990b;47:12-3. PMID 2294887
119: Millikan CH, Siekert RG, Whisnant JP. The syndrome of occlusion of the labyrinthine division of the internal auditory artery. Trans Am Neurol Assoc 1959;11. PMID 14422630
120: Min SK, Shin JH, Chang MY, et al. Impact of control of blood glucose level during treatment of sudden deafness in diabetics: relationship with prognosis. Eur Arch Otorhinolaryngol 2017;274(3):1339-43. PMID 27853944
121: Morganstern KM, Manace ED. Temporal bone histopathology in sickle cell disease. Laryngoscope 1969;79:2172-80. PMID 5362685
122: Moskowitz D, Lee KJ, Smith HW. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 1984;94:664-6. PMID 6717224
123: Mosnier I, Bouccara D, Atassi-Dumont M, Sterkers O. Treatments of idiopathic sudden sensorineural hearing loss: retrospective study of 144 cases [Article in French]. Rev Laryngol Otol Rhinol (Bord) 1998;119(2):119-28. PMID 9770055
124: Murakami T, Ono Y, Akagi N, et al. A case of superior cerebellar artery syndrome with contralateral hearing loss at onset. J Neurol Neurosurg Psychiatry 2005;76:1744-5. PMID 16291913
125: Murray A, Fields MJ. Word deafness presenting as a sudden hearing loss. Int J Clin Pract 2001;55(6):420-1. PMID 11501237
126: Na SY, Kim MG, Hong SM, Chung JH, Kang HM, Yeo SG. Comparison of sudden deafness in adults and children. Clin Exp Otorhinolaryngol 2014;7(3):165-9. PMID 25177430
127: Nakagawa T, Kumakawa K, Usami S, et al. A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment. BMC Med 2014;12:219. PMID 25406953
128: Nakagawa T, Ogino-Nishimura E, Hiraumi H, Sakamoto T, Yamamoto N, Ito J. Audiometric outcomes of topical IGF1 treatment for sudden deafness refractory to systemic steroids. Otol Neurotol 2012;33(6):941-6. PMID 22772021
129: Nakashima T, Sato H, Gyo K, et al. Idiopathic sudden sensorineural hearing loss in Japan. Acta Otolaryngol 2014;134(11):1158-63. PMID 25315915
130: Nakagawa T, Yamamoto M, Kumakawa K, et al. Prognostic impact of salvage treatment on hearing recovery in patients with sudden sensorineural hearing loss refractory to systemic corticosteroids: a retrospective observational study. Auris Nasus Larynx 2016;43(5):489-94. PMID 26739948
131: Nilsson K, Wallménius K, Hartwig S, Norlander T, Påhlson C. Bell's palsy and sudden deafness associated with Rickettsia spp. infection in Sweden. A retrospective and prospective serological survey including PCR findings. Eur J Neurol 2014;21(2):206-14. PMID 23790098
132: Noguchi Y, Takahashi M, Ito T, Fujikawa T, Kawashima Y, Kitamura K. Delayed restoration of maximum speech discrimination scores in patients with idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2016;43(5):495-500. PMID 26739945
133: Nomura Y, Mori S, Tsuchida M, Sakurai T. Deafness in cryoglobulinemia. Ann Otol Rhinol Laryngol 1982;91:250-5. PMID 7092044
134: Oas JG, Baloh RW. Vertigo and the anterior inferior cerebellar artery syndrome. Neurology 1992;42:2274-9. PMID 1461378
135: O'Connell BP, Hunter JB, Haynes DS. Current concepts in the management of idiopathic sudden sensorineural hearing loss. Curr Opin Otolaryngol Head Neck Surg 2016;24(5):413-9. PMID 27348351
136: Ohno T, Yokoyama Y, Aihara R, Mochiki E, Asao T, Kuwano H. Sudden bilateral sensorineural hearing loss as the presenting symptom of meningeal carcinomatosis of gastric cancer: report of a case. Surg Today 2010;40(6):561-5. PMID 20496139
137: Park MK, Lee CK, Park KH, Lee JD, Lee CG, Lee BD. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2011;145(6):1016-21. PMID 21817157
138: Peeters N, van der Kolk BY, Thijsen SF, Colnot DR. Lyme disease associated with sudden sensorineural hearing loss: case report and literature review. Otol Neurotol 2013;34(5):832-7. PMID 23303170
139: Penido Nde O, Ramos HV, Barros FA, Cruz OL, Toledo RN. Clinical, etiological and progression factors of hearing in sudden deafness. Braz J Otorhinolaryngol 2005;71:633-8. PMID 16612525
140: Pérez-Osorio CE, Zavala-Velázquez JE, Arias León JJ, Zavala-Castro JE. Rickettsia felis as emergent global threat for humans. Emerg Infect Dis 2008;14(7):1019-23. PMID 18598619
141: Perlman HB, Fernandez C. Experiments on temporary obstruction of the internal auditory artery. Laryngoscope 1959;69:591-613. PMID 13673604
142: Perlman HB, Kimura R. Experimental obstruction of the venous drainage and arterial supply of the inner ear. Ann Otol Rhinol Laryngol 1957;66:537-47. PMID 13459249
143: Piovesan EJ, Kowacs PA, Werneck LC, Siow C. Oscillucusis and sudden deafness in a migraine patient. Arq Neuropsiquiatr 2003;61(3B):848-50. PMID 14595494
144: Pirodda A, Ferri GG, Modungo GC, Borghi C. Systemic hypotension and the development of acute sensorineural hearing loss in young healthy subjects. Arch Otolaryngol Head Neck Surg 2001;127:1049-52. PMID 11556851
145: Rabinstein A, Jerry J, Saraf-Lavi E, Sklar E, Bradley WG. Sudden sensorineural hearing loss associated with Herpes simplex virus type 1 infection. Neurology 2001;56:571-2. PMID 11222814
146: Rambold H, Boenki G, Stritzke G, Wisst F, Neppert B, Helmchen C. Differential vestibular dysfunction in sudden unilateral heading loss. Neurology 2005;64:148-51. PMID 15642923
147: Ramos HV, Barros FA, Yamashita H, Penido Nde O, Souza AC, Yamaoka WY. Magnetic resonance imaging in sudden deafness. Braz J Otorhinolaryngol 2005;71(4):422-6. PMID 16446954
148: Rauch SD. Idiopathic sudden sensorineural hearing loss. N Engl J Med 2008;359:833-40. PMID 18716300
149: Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA 2011;305(20):2071-9. PMID 21610239
150: Raupp SF, Jellema K, Sluzewski M, de Kort PL, Visser LH. Sudden unilateral deafness due to a right vertebral artery dissection. Neurology 2004;62:1442. PMID 15111698
151: Reiss M, Reiss G. Laterality of sudden sensorineural hearing loss. Ear Nose Throat J 2014;93(8):318-20. PMID 25181661
152: Rozsasi A, Sigg O, Keck T. Persistent inner ear injury after diving. Otol Neurotol 2003;24(2):195-200. PMID 12621331
153: Ruben RJ, Distenfeld A, Berg P, Carr R. Sudden sequential deafness as the presenting symptom of macroglobulinemia. JAMA 1969;209:1364-5. PMID 4979452
154: Ryu IS, Yoon TH, Ahn JH, Kang WS, Choi BS, Lee JH, Shim MJ. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging in sudden sensorineural hearing loss: correlations with audiologic and vestibular testing. Otol Neurotol 2011;32(8):1205-9. PMID 21921851
155: Saadah HA. Vestibular vertigo associated with hyperlipidemia: response to antilipemic therapy. Arch Intern Med 1993;153:1846, 9. PMID 8333820
156: Sakata T, Esaki Y, Yamano T, Sueta N, Nakagawa T. A comparison between the feeling of ear fullness and tinnitus in acute sensorineural hearing loss. Int J Audiol 2008;47:134-40. PMID 18307093
157: Samuelsson AK, Hyden D, Roberg M, Skogh T. Evaluation of anti-hsp70 antibody screening in sudden deafness. Ear Hear 2003;24(3):233-5. PMID 12799545
158: Sando I, Ogawa A, Jafek BW. Inner ear pathology following injury to the eighth cranial nerve and the labyrinthine artery. Ann Otol 1982;91:136-41. PMID 6979284
159: Sauvaget E, Kici S, Petelle B, et al. Vertebrobasilar occlusive disorders presenting as sudden sensorineural hearing loss. Laryngoscope 2004;114:327-32. PMID 14755213
160: Schick B, Brors D, Koch O, Schafers M, Kahle G. Magnetic resonance imaging in patients with sudden hearing loss, tinnitus and vertigo. Otol Neurotol 2001;22:808-12. PMID 11698800
161: Schweitzer VG, Darrat I, Stach BA, Gray E. Sudden bilateral sensorineural hearing loss following polysubstance narcotic overdose. J Am Acad Audiol 2011;22(4):208-14. PMID 21586255
162: Seltzer S, Mark AS. Contrast enhancement of the labyrinth on MR scans in patients with sudden hearing loss and vertigo: evidence of labyrinthine disease. AJNR 1991;12:13-6. PMID 1899498
163: Shao M, Xiong G, Xiang G, Xu S, Zheng Y, Zhang L. Sudden deafness as an initial presentation of varicella: case report and literature review. Ann Palliat Med 2021;10(5):5891-6. PMID 34107725
164: Sherlock S, Thistlethwaite K, Rubini A, Khatun M, Perry C, Tabah A. Hyperbaric oxygen therapy in the treatment of sudden sensorineural hearing loss: a retrospective analysis of outcomes. Diving Hyperb Med 2016;46(3):160-5. PMID 27723017
165: Sheu JJ, Wu CS, Lin HC. Association between obstructive sleep apnea and sudden sensorineural hearing loss: a population-based case-control study. Arch Otolaryngol Head Neck Surg 2012;138(1):55-9. PMID 22249630
166: Shin SH, Chun YM, Lee HK. A cochlear schwannoma presenting with sudden hearing loss. Eur Arch Otorhinolaryngol 2008;265:839-42. PMID 18004581
167: Sismanis A. Diagnostic and management dilemma of sudden hearing loss. Arch Otolaryngol Head Neck Surg 2005;131:733-4. PMID 16103309
168: Song JJ, Mertens G, Deleye S, et al. Neural substrates of conversion deafness in a cochlear implant patient: a molecular imaging study using H₂¹⁵O-PET. Otol Neurotol 2014;35(10):1780-4. PMID 25166017
169: Spear SA, Schwartz SR. Intratympanic steroids for sudden sensorineural hearing loss: a systematic review. Otolaryngol Head Neck Surg 2011;145(4):534-43. PMID 21873598
170: Stachler RJ, Chandrasekhar SS, Archer SM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146(3 Suppl):S1-35. PMID 22383545
171: Stahl N, Cohen D. Idiopathic sudden sensorineural hearing loss in the only hearing ear: patient characteristics and hearing outcome. Arch Otolaryngol Head Neck Surg 2006;132:193-5. PMID 16490878
172: Stokroos RJ, Albers FW. The etiology of idiopathic sudden sensorineural hearing loss: a review of the literature. Acta Otorhinolaryngol Belg 1996;50:69-76. PMID 8669276
173: Stokroos RJ, Albers FW, Krikke AP, Casselman JW. Magnetic resonance imaging of the inner ear in patients with idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 1998b;255:433-6. PMID 9833208
174: Stokroos RJ, Albers FW, Tenvergert EM. Antiviral treatment of idiopathic sudden sensorineural hearing loss: a prospective, randomized, double-blind clinical trial. Acta Otolaryngol 1998a;118:488-95. PMID 9726671
175: Strupp M, Planck JH, Arbusow V, et al. Rotational vertebral artery occlusion syndrome with vertigo due to "labyrinthine excitation." Neurology 2000;54:1376-9. PMID 10746615
176: Sun H, Hu J, Mao Z, Ma Z. Efficacy of combination therapy in adolescent and adult patients with total-deafness sudden sensorineural hearing loss. Acta Otolaryngol 2019;139(3):258-62. PMID 30762471
177: Sun B, Liu L, Ren X, Wang Z. Psychological state of patients with sudden deafness and the effect of psychological intervention on recovery. J Int Med Res 2020;48(9):300060520957536. PMID 32967513
178: Suzuki H, Mori T, Hashida K, Shibata M, Nguyen KH, Wakasugi T, Hohchi N. Prediction model for hearing outcome in patients with idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2011;268(4):497-500. PMID 21042804
179: Suzuki H, Wakasugi T, Kitamura T, Koizumi H, Do BH, Ohbuchi T. Comparison of 2 and 4 intratympanic steroid injections in the treatment of idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 2018;127(4):235-40. PMID 29411622
180: Toyoda K, Hirano T, Kumai Y, et al. Bilateral deafness as a prodromal symptom of basilar artery occlusion. J Neurol Sci 2002;193:147-50. PMID 11790395
181: Tsounis M, Psillas G, Tsalighopoulos M, Vital V, Maroudias N, Markou K. Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial. Eur Arch Otorhinolaryngol 2018;275(1):103-10. PMID 29168028
182: Tucci DL. Sudden sensorineural hearing loss: a viral etiology. Arch Otolaryngol Head Neck Surg 2000;126:1164-5. PMID 10979138
183: Vazquez R, Solanellas J, Alfageme I, et al. Mitral valve prolapse and sudden deafness. Int J Cardiol 2008;124:370-1. PMID 17363095
184: Verghese J, Morocz IA. Acute unilateral deafness. J Otolaryngol 1999;28:362-4. PMID 10604169
185: Wang CT, Chou HW, Fang KM, Lai MS, Cheng PW. Treatment outcome of additional dextran to corticosteroid therapy on sudden deafness: propensity score-matched cohort analysis. Otolaryngol Head Neck Surg 2012;147(6):1125-30. PMID 22910305
186: Watanabe Y, Ohi H, Shojaku H, Mizukoshi K. Sudden deafness from vertebrobasilar artery disorder. Am J Otol 1994;15:423-6. PMID 8579154
187: Weber PC, Zbar RI, Gantz BJ. Appropriateness of magnetic resonance imaging in sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 1997;116:153-6. PMID 9051056
188: Wei BP, Stathopoulos D, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2013;7:CD003998. PMID 23818120
189: Weng SF, Chen YS, Hse CJ, Tseng FY. Clinical features of sudden sensorineural hearing loss in diabetic patients. Laryngoscope 2005;115:1676-80. PMID 16148716
190: Wilson WR. The relationship of the Herpesvirus family to sudden hearing loss: a prospective clinical study and literature review. Laryngoscope 1986;96:870-7. PMID 3016434
191: Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol 1980;106:772-6. PMID 7002129
192: Wu HP, Chou YF, Yu SH, Wang CP, Hsu CJ, Chen PR. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study. Otol Neurotol 2011;32(5):774-9. PMID 21646929
193: Xie S, Qiang Q, Mei L, et al. Multivariate analysis of prognostic factors for idiopathic sudden sensorineural hearing loss treated with adjuvant hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol 2018;275(1):47-51. PMID 29071444
194: Yamasoba T, Kikuchi S, Higo R. Deafness associated with vertebrobasilar insufficiency. J Neurol Sci 2001;187:69-75. PMID 11440747
195: Yang TH, Xirasagar S, Cheng YF, Chen CS, Lin HC. Increased prevalence of hearing loss, tinnitus and sudden deafness among patients with Sjögren's syndrome. RMD Open 2024;10(1):e003308. PMID 38242553
196: Yimtae K, Srirompotong S, Kraitrakul S. Idiopathic sudden sensorineural hearing loss. J Med Assoc Thai 2001;84:113-9. PMID 11281488
197: Yin T, Huang F, Ren J, et al. Bilateral sudden hearing loss following habitual abortion: a case report and review of literature. Int J Clin Exp Med 2013;6(8):720-3. PMID 24040484
198: Yoon TH, Paparella MM, Schachern PA, Alleva M. Histopathology of sudden hearing loss. Laryngoscope 1990;100:707-15. PMID 2362530
199: Zadeh MH, Storper IS, Spitzer JB. Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients. Otolaryngol Head Neck Surg 2003;128:92-8. PMID 12574765
200: Zavod MB, Sataloff RT, Rao VM. Frequency of cochlear enhancement on magnetic resonance imaging in patients with autoimmune sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2000;126:969-71. PMID 10922229
201: Zhang BY, Young YH. Sudden deafness during antepartum versus postpartum periods. ORL J Otorhinolaryngol Relat Spec 2017;79(5):274-81. PMID 28982103
202: Zhou F, Wang Z, Huang Y, Chen X. Application of inner ear MRI after intravenous gadolinium injection in SSNHL. Acta Otolaryngol 2023;143(1):1-5. PMID 36650911

ICD & OMIM codes

ICD-10: Sudden idiopathic hearing loss: H91.2
ICD-11: Sudden idiopathic hearing loss: AB55

Sudden deafness disorder (TM1): SC80

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Sudden deafness

Differential Diagnosis

inner ear ischemia
eighth nerve ischemia
viral infection of the labyrinth or cochlear nerve
Ménière disease
intralabyrinthine membrane rupture
- autoimmune or inflammatory causes
- retrocochlear masses
- demyelinating disease
- syphilis
- Lyme disease
- Rickettsia felis infection
- meningitis
- carcinomatous meningitis
- Takayasu arteritis
- chronic sinusitis
- prior radiation therapy for nasopharyngeal carcinoma
- perilymph fistula
- toxins
- barotrauma
- head injury
- otologic surgery
- vestibular schwannoma
- demyelinating disease
- stroke
- vertebrobasilar occlusive disease
- carcinomatous meningitis
- paraneoplastic syndromes
- encephalitis
- meningitis
- thromboemboli of the posterior circulation
- migraine
- fat emboli
- thromboangiitis obliterans
- hyperlipidemia
- macroglobulinemia
- sickle cell disease
- leukemia
- polycythemia vera
- other causes of hypercoagulation or hyperviscosity
- hypotension
- cochlea dysfunction from ischemia
- mixed central and peripheral vestibular dysfunction
- posterior inferior cerebellar artery territory infarction (Wallenberg syndrome)
- Ramsay Hunt syndrome
- acoustic neuroma
- cochlear schwannoma
- medication use, including nonsteroidal anti-inflammatory drugs, aminoglycosides, or phosphodiesterase inhibitors
- psychogenic sudden deafness

Also Relevant

Autoimmune sensorineural hearing loss
Central deafness
Labyrinthine infarction
Sporadic schwannomas and neurofibromas
Susac syndrome
- Vestibular schwannoma

Sudden deafness …

Sudden deafness

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Anatomic localization

Pathophysiology

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

References

Contributors

Author

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Brain death/death by neurologic criteria

Hepatic encephalopathy

Bowel dysfunction in neurologic disorders

Coma due to primary brainstem and diencephalic lesions

Giant cell arteritis

Ischemic optic neuropathy

Transient visual loss

Vestibular schwannoma

Sudden deafness

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Anatomic localization

Pathophysiology

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

References

Contributors

Author

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Brain death/death by neurologic criteria

Hepatic encephalopathy

Bowel dysfunction in neurologic disorders

Coma due to primary brainstem and diencephalic lesions

Giant cell arteritis

Ischemic optic neuropathy

Transient visual loss

Vestibular schwannoma

This is an article preview.
Start a Free Account
to access the full version.